8-K: LanzaTech Global Amends Preferred Stock and Warrant Agreements, Extends Key Financing and Approval Deadlines

LanzaTech Global, Inc. has amended its Series A Convertible Senior Preferred Stock Purchase Agreement and related documents, extending deadlines for warrant issuance, stockholder approvals, and a crucial subsequent financing, while clarifying preferred stock terms and redemption triggers.

Summary

• LanzaTech Global, Inc. (LNZA) has entered into Amendment No. 1 to its Series A Convertible Senior Preferred Stock Purchase Agreement with LanzaTech Global SPV, LLC, an entity controlled by an existing investor.
• The amendment extends the deadline for the Company to issue warrants to the Purchaser for an aggregate of 780,000,000 shares of common stock at an exercise price of $0.0000001 per share. This issuance is now tied to the consummation of a Subsequent Financing or Other Financing, provided it occurs by May 7, 2026.
• The deadline for obtaining written consent from BGTF Aggregator LP has been extended to June 6, 2025; failure to secure this consent will trigger a mandatory redemption event for the Series A Preferred Stock.
• The Company's deadline to convene a stockholder meeting for Requisite Stockholder Approvals (including approval for common stock issuance upon preferred stock conversion and warrant exercise, and a potential 100:1 reverse stock split) has been extended to no later than 75 days following May 7, 2025, or 90 days if the SEC reviews the preliminary proxy statement.
• The deadline for consummating the Subsequent Financing, which aims to raise between $35,000,000 and $60,000,000 at $0.05 per share, has been extended to no later than 45 days after receiving the Requisite Stockholder Approvals.
• The Amended and Restated Certificate of Designation for the Series A Convertible Senior Preferred Stock (20,000,000 shares issued at $2.00 per share) clarifies its senior ranking, 8% cumulative preferential dividends (accruing quarterly and added to liquidation value), and conversion rights.
• Holders of Series A Preferred Stock have significant protective provisions, including the right to elect one director and negative covenants requiring their consent for major corporate actions like other financings, charter amendments, and material asset sales.
• The Purchaser also waived the Company's obligation to file the Registration Statement by June 6, 2025, with a new deadline set for the earlier of 45 days post-Requisite Stockholder Approvals or 10 business days post-Warrant Shares issuance.

Sentiment

Score: 3

Explanation: The filing indicates ongoing challenges in securing necessary approvals and completing financing, evidenced by multiple deadline extensions. The terms of the planned subsequent financing and warrants suggest significant potential dilution for existing common shareholders, and a critical near-term condition (BGTF consent) poses a mandatory redemption risk.

Positives

• Extensions provide the company more time to secure necessary stockholder approvals and complete the Subsequent Financing, potentially avoiding immediate default on certain obligations.
• The Series A Preferred Stock terms include an 8% cumulative preferential dividend, providing a fixed return for the investor.
• The preferred stock has strong protective provisions, including senior ranking in liquidation, significant voting rights (Series A Director election), and negative covenants, which protect the investor's position.

Negatives

• The need for multiple deadline extensions suggests potential challenges in securing stockholder approvals or completing the Subsequent Financing as initially planned.
• Failure to obtain BGTF Aggregator LP consent by June 6, 2025, triggers a mandatory redemption event for the Series A Preferred Stock, indicating a critical short-term condition and potential financial strain.
• The potential 100:1 reverse stock split, if approved, often signals a low stock price and can be perceived negatively by the market, potentially impacting investor confidence.
• The Subsequent Financing price of $0.05 per share is significantly lower than the preferred stock's original issue price of $2.00 per share, indicating substantial dilution for existing common shareholders if the financing occurs.
• The exercise price of the warrants ($0.0000001 per share) is extremely low, implying significant potential dilution from warrant exercise.

Risks

• Failure to Obtain Stockholder Approvals: The Company requires 'Requisite Stockholder Approvals' for the issuance of Common Stock upon conversion of Preferred Stock, exercise of Warrants, and the Subsequent Financing, as well as a potential reverse stock split. Failure to obtain these approvals could jeopardize the financing and warrant issuance.
• Failure to Obtain BGTF Aggregator LP Consent: Not obtaining this consent by June 6, 2025, triggers a mandatory redemption event for the Series A Preferred Stock, which could lead to significant financial strain or default.
• Inability to Consummate Subsequent Financing: The Company needs to raise $35,000,000 to $60,000,000 through a Subsequent Financing. Failure to do so could impact its capital position and operations.
• Dilution Risk: The issuance of 780,000,000 Warrant Shares at an extremely low exercise price ($0.0000001) and the Subsequent Financing at $0.05 per share pose significant potential dilution to existing common shareholders.
• Liquidation and Redemption Risks: The Series A Preferred Stock has strong liquidation preferences and mandatory redemption triggers (e.g., Change of Control, Liquidation Event, Insufficient Capitalization Event, Uncured Company Breach), which could lead to significant payouts to preferred holders in adverse scenarios, potentially at the expense of common shareholders.
• Regulatory Review Risk: SEC review of the preliminary proxy statement could further delay the stockholder meeting and subsequent financing.

Future Outlook

The company is working to secure necessary stockholder approvals and complete a significant subsequent financing round to bolster its capital. The successful execution of these steps, including obtaining the BGTF Aggregator LP consent and Requisite Stockholder Approvals, is crucial for the issuance of warrants and the overall financial stability and capital structure adjustments.

Management Comments

• The Company and the Purchaser mutually agreed to extend the date for the Company to issue and sell warrants.
• The Company agreed to file the Registration Statement no later than the earlier of (i) 45 calendar days following receipt of the Requisite Stockholder Approvals and (ii) 10 business days following the issuance of the Warrant Shares.

Industry Context

This filing primarily concerns corporate financing and governance adjustments rather than operational or industry-specific developments. It reflects a company seeking to secure its financial foundation and manage its capital structure, which is a common activity across various industries, especially for growth-stage or capital-intensive companies. The terms of the financing and the need for a reverse stock split suggest the company is navigating a challenging financial environment.

Corporate Governance

Related Party Transactions

• The Series A Convertible Senior Preferred Stock was issued to LanzaTech Global SPV, LLC, an entity controlled by an existing investor.
• The Purchaser (LanzaTech Global SPV, LLC) holds 100% of the Series A Preferred Shares outstanding and is the counterparty to the amendments and waivers.

Stakeholder Impact

• Shareholders (Common Stock): Significant potential dilution from the issuance of 780,000,000 warrant shares at an extremely low exercise price ($0.0000001) and the Subsequent Financing at $0.05 per share. A potential 100:1 reverse stock split could also impact per-share metrics and market perception.
• Preferred Shareholders (LanzaTech Global SPV, LLC): Their investment is protected by senior ranking, an 8% cumulative dividend, significant voting rights (Series A Director), and strong negative covenants requiring their consent for major corporate actions. They also have mandatory redemption rights under specific adverse conditions.
• Creditors: The senior ranking of the Series A Preferred Stock means preferred holders would be paid before common shareholders in a liquidation event, but after other creditors. Mandatory redemption events could impact the company's liquidity.

Next Steps

• Obtain written consent from BGTF Aggregator LP by June 6, 2025.
• Convene a meeting of stockholders to obtain Requisite Stockholder Approvals (including for common stock issuance, warrant exercise, and a potential 100:1 reverse stock split) by approximately July 21, 2025 (or later if SEC reviews proxy statement).
• Consummate the Subsequent Financing (raising $35,000,000-$60,000,000) no later than 45 days following receipt of Requisite Stockholder Approvals.
• Issue warrants for 780,000,000 shares of common stock upon satisfaction of Conditions to Exercise (Requisite Stockholder Approvals and Financing).
• File a Registration Statement for resale of Preferred Common Shares and Warrant Shares no later than the earlier of 45 calendar days following Requisite Stockholder Approvals or 10 business days following Warrant Shares issuance.

Key Dates

Recommendation

Keywords

LanzaTech Global, LNZA, SEC Filing, 8-K, Preferred Stock, Convertible Preferred Stock, Warrants, Stockholder Approval, Capital Raise, Financing, Dilution, Corporate Governance, Risk Management, Nasdaq, Reverse Stock Split